Hypothesis

Chronic metabolic stress in the amygdala drives AMPK‑dependent autophagy that selectively degrades the A‑type potassium channel Kv4.2 in corticotropin‑releasing factor (CRF)‑expressing neurons, thereby increasing neuronal excitability and sustaining anxiety‑like behaviors without impairing fear extinction.

Mechanistic Model

1. Energy siege triggers AMPK hyperactivation – prolonged glucocorticoid elevation or nutrient scarcity raises AMP/ATP ratios, activating AMPK in amygdala CRF neurons (consistent with [1] and [5]).
2. AMPK phosphorylates Kv4.2 at Ser616 – this modification creates a recognition site for the autophagy receptor p62/SQSTM1, coupling the channel to the phagophore.
3. Selective autophagic removal of Kv4.2 – unlike bulk cytosolic cargo, Kv4.2 is preferentially engulfed because its phosphorylated C‑terminus binds p62 with high affinity, leading to lysosomal degradation.
4. Loss of A‑type potassium current accelerates firing – Kv4.2 normally dampens rapid depolarizations; its reduction lowers the threshold for action potential generation, increasing CRF release and amygdala output.
5. Behavioral output – heightened CRF signaling maintains amygdala‑driven anxiety phenotypes, while fear extinction circuitry (hippocampus‑mPFC) remains intact because Kv4.2 loss is restricted to CRF cells.

Predictions & Tests

• Prediction 1: AMPK activation in amygdala CRF neurons increases Kv4.2 ubiquitination and p62 colocalization. Test: Perform proximity ligation assay (PLA) for Kv4.2‑p62 after pharmacological AMPK activation (AICAR) in CRF‑Cre mice; quantify puncta via confocal microscopy.
• Prediction 2: Preventing Kv4.2 phosphorylation (Ser616Ala knock‑in) blocks autophagy‑mediated channel loss and rescues anxiety without affecting extinction learning. Test: Cross CRF‑Cre mice with a Kv4.2‑S616A knock‑in line; assess elevated‑plus maze and open‑field behavior, and fear extinction retention after autophagic flux modulation (chloroquine or bafilomycin).
• Prediction 3: Acute pharmacological inhibition of autophagy (e.g., with SAR405) restores Kv4.2 surface expression and normalizes firing rates in amygdala slices from stressed animals. Test: Whole‑cell patch clamp in amygdala CRF neurons measuring A‑type current before and after SAR405 application; compare to vehicle.
• Prediction 4: Viral overexpression of a non‑degradable Kv4.2 (ΔC‑terminus lacking p62 binding site) in amygdala CRF neurons reduces anxiety‑like behavior in PTSD‑model rats. Test: Inject AAV‑Kv4.2‑ΔC into the basolateral amygdala of rats subjected to prolonged restraint; evaluate anxiety measures and c‑Fos activation.

Falsifiable Outcomes

If Kv4.2 degradation is not required for anxiety persistence, then (a) preventing its phosphorylation or degradation will not alter anxiety phenotypes despite confirmed autophagy flux changes, or (b) rescuing Kv4.2 surface levels will fail to normalize neuronal excitability or behavior. Such results would refute the selective channel‑degradation mechanism and suggest alternative autophagy substrates drive the siege phenotype.

Broader Implications

This model reframes autophagy in anxiety disorders from a nonspecific cleanup process to a precise ion‑channel triage that rewires circuit excitability. It offers a druggable axis—targeting the Kv4.2‑p62 interaction or AMPK‑dependent phosphorylation—that could alleviate pathological anxiety while preserving adaptive fear learning.